(±)-Equol
Product Sizes
25 mg
HY-100583A-25MG
100 mg
HY-100583A-100MG
10 mg
HY-100583A-10MG
200 mg
HY-100583A-200MG
50 mg
HY-100583A-50MG
5 mg
HY-100583A-5MG
10mM/1mL
HY-100583A-10MM
About this Product
- SKU:
- HY-100583A
- Application:
- Antibody Microarray
- CAS Number:
- 94105-90-5
- Extra Details:
- (±)-Equol is the racemate of equol. (±)-equol exhibits EC50s of 200 and 74 nM for human ERα and ERβ; respectively. Equol is a metabolite of the soy isoflavones; daidzin and daidzein.
- Molecular Weight:
- 242.27
- Purity:
- 99.79
- References:
- [1]Axelson M, et al. The identification of the weak oestrogen equol [7-hydroxy-3-(4'-hydroxyphenyl)chroman] in human urine. Biochem J. 1982 Feb 1;201(2):353-7.|[2]Setchell KD, et al. S-equol, a potent ligand for estrogen receptor beta, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora. Am J Clin Nutr. 2005 May;81(5):1072-9. human intestinal bacterial flora.|[3]Wang J, et al. Equol promotes rat osteoblast proliferation and differentiation through activating estrogen receptor. Genet Mol Res. 2014 Jul 4;13(3):5055-63.|[4]Gimenez I,et al. Renal and vascular actions of equol in the rat. J Hypertens. 1997 Nov;15(11):1303-8.|[5]Choi EJ, et al. Anticancer mechanism of equol in 7,12-dimethylbenz(a)anthracene-treated animals. Int J Oncol. 2011 Sep;39(3):747-54.|[6]Charoenthongtrakul S, et al. Enhanced gastrointestinal motility with orally active ghrelin receptor agonists. J Pharmacol Exp Ther. 2009;329(3):1178-1186.
- Research Area:
- Cancer; Neurological Disease; Cardiovascular Disease
- Shipping Conditions:
- Ambient
- Storage Conditions:
- -20[o]C; 3 years; 4[o]C; 2 years (Powder)
- Type:
- Proteins, Peptides, Small Molecules & Other Biomolecules: Small Molecules
- Pathway:
- Metabolic Enzyme/Protease;Vitamin D Related/Nuclear Receptor
